Table:
begin	end	state
1	16	cytoplasmic
17	41	transmembrane
42	54	non-cytoplasmic
55	76	transmembrane
77	83	cytoplasmic
84	104	transmembrane
105	110	non-cytoplasmic
111	130	transmembrane
131	141	cytoplasmic
142	166	transmembrane
167	171	non-cytoplasmic
172	193	transmembrane
194	253	cytoplasmic
254	274	transmembrane
275	288	non-cytoplasmic
289	309	transmembrane
310	315	cytoplasmic
316	334	transmembrane
335	339	non-cytoplasmic
340	357	transmembrane
358	377	cytoplasmic
378	400	transmembrane
401	407	non-cytoplasmic
408	427	transmembrane
428	446	cytoplasmic

Input:
>RR42_RS21935
MDVQQFIDSQPFSRFQWIILILCFLIVAADGFDTAAIGFIAPMLAKEWGVSRAHLGPVMS
AALFGLAAGALVAGPLADRFGRKGVLVGSVLCFGGWSVASAFASSLEALTVLRFLTGLGL
GAAMPNAVTLMSEYAPTRRRSLAVNAMFCGFTLGSSAGGFAAAWLIPHYGWHSVLLVGGV
APLLLAVLLILFLPESVRFLVARKAPDARIAAALSKVHPGVLRADERFHVQEAAPTGASS
LRTILMPQFRSGTVLLWTTYFMGLLIFYLLTSWLPTLFADAGYPIEKAALITALFPLGGG
IGTLTVGWLMDRGHPWRIVAGTYALTGALVYAVGHGAGDVFLLGVLVFAAGTCMNGAQSS
MPTLAAGFYPTQCRATGVAWMLGIGRFGGIAGALLGAQILGLGWSFGKIFGLLSLPAFVA
TAALLIASARPRAAVRPAVGQHDAAH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server